Objectives-To establish the clinical significance of isolated nail fold vasculitis in patients with rheumatoid arthritis (RA). Methods-Patients attending hospital with established RA were assessed by a single observer using unaided vision. Isolated nail fold vasculitis (NFV) was diagnosed as small nail edge or nail fold lesions without any evidence of other extraarticular or systemic vasculitis. Patients were followed prospectively. Results-Thirty patients with isolated NFV were identified and followed for a median interval of 22 months. Three patients died within three months of diagnosis and six developed complications possibly indicative of extra-articular disease: xerostomia (three), pericarditis (one), pleural effusion and empyaema (one), pulmonary fibrosis (one). No patient developed systemic vasculitis. Conclusion-Isolated NFV has a favourable prognosis compared with systemic vasculitis. There is a low risk ofdeveloping systemic or extra-articular disease.
Vasculitis is an uncommon but potentially serious complication of rheumatoid arthritis (RA), which can involve all sizes of vessel from aorta to capillaries. Isolated small nail fold or nail edge lesions (nail fold vasculitis (NFV)) reflecting mainly small vessel involvement are common and may easily be missed. These lesions are usually transient and possibly related to local trauma.'`3 As with other extraarticular manifestations of RA such as pericarditis,4 the reported incidence of these lesions reflects the intensity of the search. 5 They have been reported in up to 34% of men and 18% of women with classical RA attending hospital.' Subclinical small vessel vasculitis has been reported in up to 30% of biopsy specimens from clinically uninvolved skin taken from RA patients.6 7 Isolated NFV is generally believed to be a benign and relatively minor feature of RA,2 though it may herald the onset of major arteritis, as described by trexate is known to accelerate nodule formaree patients (two women) died at three tion; whether it can also precipitate vasculitis two months, and three months, respect-is uncertain. Because of the retrospective after NFV was first noted (figure). Post-nature of the case note review, it was not :m examination of one did not show any possible to assess whether changes in cortiace of SRV; the second death was costeroid or methotrexate dose occurred ally attributed to interstitial lung disease, shortly before the onset of vasculitis. had not been clinically suspected at the Six patients with isolated NFV developed NFV was first observed, and the third complications. Three patients developed was believed to be attributable to athero-xerostomia; labial gland biopsy specimens were is ischaemic heart disease. The mortality not examined and it cannot be excluded that t 24 months was 10% (95% confidence the xerostomia represented age related al 0-27%) for the NFV patients and 27% mucosal dryness. One patient developed peri-%) for patients with SRV. There was no carditis (documented as audible rub and a icant difference in mortality between pericardial effusion visible on the echocardio- The mechanism ofNFV may differ from that of SRV. Nail fold lesions have been attributed to local trauma,3 whilst systemic vasculitis is considered to be immune mediated.9 Clinically, however, there are similarities between the two groups. Patients with NFV or SRV are similar in age and in duration of RA, and are typically seropositive for rheumatoid factor, with nodules and erosions. There is an excess of male patients in both groups, compared with the marked female preponderance in uncomplicated RA. Nail fold lesions were present in 68% of our patients with SRV. Isolated NFV and SRV may represent opposite ends of a spectrum of vasculitic manifestations in RA, with NFV representing milder 'benign' disease and SRV more severe vascular involvement. That there is little progression from benign to severe is suggested by the similarity of age and disease duration of NFV and SRV patients. There is a trend towards NFV patients being older with longer disease duration; if isolated NFV was a precursor of SRV, it would be expected that the NFV patients would be younger, with a shorter disease duration than patients presenting with SRV.
We have reported a higher annual incidence of SRV (12'5/million) than previous estimates; whether this represents a true increase, or increased diagnostic zeal is uncertain.'5 This suggests, however, that RA is not becoming less severe, as has been suggested. '6 The incidence of NFV is unknown and is difficult to establish because of its evanescent nature.
We conclude that development of NFV rarely heralds the imminent onset of SRV. NFV does not have the poor prognosis of SRV, and does not require aggressive immunosuppressive treatment.
